High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME)
Left ventricular hypertrophy (LVH) caused by cardiac variant Fabry disease (FD) is typically late-onset and may mimic LVH caused by abnormal loading conditions. We aimed to determine the prevalence of FD in a non-selective patient population of everyday practice presenting with LVH, including those...
Main Authors: | Yiting Fan, Tsz-Ngai Chan, Josie T. Y. Chow, Kevin K. H. Kam, Wai-Kin Chi, Joseph Y. S. Chan, Erik Fung, Mabel M. P. Tong, Jeffery K. T. Wong, Paul C. L. Choi, David K. H. Chan, Bun Sheng, Alex Pui-Wai Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/10/2160 |
Similar Items
-
Fabry Cardiomyopathy: Current Practice and Future Directions
by: Jeffrey Yim, et al.
Published: (2021-06-01) -
Fabry Cardiomyopathy: Current Treatment and Future Options
by: Irfan Vardarli, et al.
Published: (2021-07-01) -
Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
by: Jefferson Loso, et al.
Published: (2018-08-01) -
Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
by: Andrea Frustaci, et al.
Published: (2018-09-01) -
Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy
by: Maria Xu, et al.
Published: (2020-12-01)